Anti-TNF medications used to control arthritis symptoms have been linked to increased risks for skin infections. However, a recent study has shown that this may not necessarily be true.

A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.

Early reports indicating drugs treating psoriasis were linked to major cardiovascular events seem to lack evidence.